Centessa Pharmaceuticals plc Financial Ratios
CNTA / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-37.5%
Profit Margin
-1316.9%
Net Income / Revenue
Asset Turnover
0.02
Revenue / Total Assets
Equity Multiplier
1.30
Total Assets / Equity
Composite: -37.5% (reported: -37.5%)
Profitability
Liquidity
Current Ratio
8.57
Quick Ratio
8.57
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.02
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2025 · SEC 10-K · Updated Jul 2, 2026
Earnings Quality
Accrual Ratio
-0.6%
+15.7pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.